Category: Pharma

  • MODERNA TO USE mRNA FOR HIV AND CANCER AFTER COVID-19

    MODERNA TO USE mRNA FOR HIV AND CANCER AFTER COVID-19

    , , , ,

    ·

    By

    Swikriti Chauhan

    –

    Moderna has developed several drugs with its cost and time effective mRNA technology that are currently undergoing trials for HIV, cancer, heart diseases and genetic disorders that could potentially lead to a paradigm shift in the way medicines are developed and manufactured. The company currently has vaccines for 10 viruses in trials including one for…

  • LAMBDA : NEW VARIANT WITH 7 MUTATIONS

    LAMBDA : NEW VARIANT WITH 7 MUTATIONS

    , , ,

    ·

    By

    Swikriti Chauhan

    –

    Lambda, a new coronavirus variant has been declared as a “variant of interest” by the World Health Organization (WHO). 31 countries including United States, United Kingdom, France, Italy, Germany and Switzerland etc., have reported the cases of this variant. Originated in Peru in December 2020, now this particular variant accounts for almost 82% of the total…

  • INDIA ADMINISTERED OVER 32 CRORE DOSES, OVERTAKES US

    INDIA ADMINISTERED OVER 32 CRORE DOSES, OVERTAKES US

    , ,

    ·

    By

    Swikriti Chauhan

    –

    Health ministry on Monday informed that as many as 32.8 crore doses of Covid-19 vaccines have been administered since the start of the vaccination drive that began from January 16. Out of these, one crore healthcare workers took the first dose and 72 lakh got the second dose as well. Following a new policy, India has…

  • NINE EUROPEAN COUNTRIES APPROVE INDIAN VACCINE COVISHIELD FOR GREEN PASS

    NINE EUROPEAN COUNTRIES APPROVE INDIAN VACCINE COVISHIELD FOR GREEN PASS

    , ,

    ·

    By

    Swikriti Chauhan

    –

    European countries including, Austria, Germany, Slovenia, Greece, Estonia, Iceland, Ireland and Spain, and Switzerland have approved the Covishield COVID-19 vaccine for ‘Green Pass’. This comes after India has asked the European countries to allow entry to Indians vaccinated with Covishield or Covaxin. The Green Pass has been rolled out on July 1 to facilitate free…

  • ZYDUS CADILA’S VACCINE TO BE JUST AS EFFECTIVE WITH A TWO- DOSE REGIMEN

    ZYDUS CADILA’S VACCINE TO BE JUST AS EFFECTIVE WITH A TWO- DOSE REGIMEN

    , ,

    ·

    By

    Swikriti Chauhan

    –

    Highlights: Fifth vaccine to be authorized in India. Now effective with two doses. Company to manufacture 120M doses a year. If approved, it could be World’s first plasmid DNA shot. Zydus Cadila, a leading Indian Pharmaceutical company is seeking approval from the DCGI for the EUA of its Covid-19 vaccine candidate, ZyCoV-D. It is the…

  • SII TO SUPPLY 20 CRORE COVAVAX DOSES BY DEC 2021

    SII TO SUPPLY 20 CRORE COVAVAX DOSES BY DEC 2021

    , ,

    ·

    By

    Swikriti Chauhan

    –

    The Maryland based company, Novavax’s covid-19 vaccine candiate, named Covavax in India is all set to be launched in August-September this year in association with the Pune based Serum Institute of India. The vaccine has shown 90% efficacy in the clinical trials conducted in the U.S. With U.S. easing the availability of the key raw…

  • FIRST DEATH FOLLOWING COVID-19 VACCINATION

    FIRST DEATH FOLLOWING COVID-19 VACCINATION

    , ,

    ·

    By

    Swikriti Chauhan

    –

    A 68 year old man has died after being fully vaccinated with the covishield vaccine in the month of March due to anaphylaxis, which is considered as a severe allergic reaction that could happen post vaccination. In a report submitted by the AEFI Committee, it has been reported that the cause of death is a…

  • Concern of rising SARS-CoV2 Variants and Mutations

    Concern of rising SARS-CoV2 Variants and Mutations

    , ,

    ·

    By

    Swikriti Chauhan

    –

    As new variants of SARS-Cov2 the official title given to the COVID-19 virus, continue to arise, similar transformations are discovered by the scientists, making the infection more problematic and destructive. This article primarily focuses on those changes called mutations. What happens during mutations? Once a virus gets into our body, it latches onto one of…

  • GOVERNMENT TO RESERVE 30 CRORE DOSES OF BIOLOGICAL E’S NEW VACCINE

    GOVERNMENT TO RESERVE 30 CRORE DOSES OF BIOLOGICAL E’S NEW VACCINE

    , ,

    ·

    By

    Swikriti Chauhan

    –

    Biological E, a Hyderabad-based vaccine and pharmaceutical company, has announced that it has successfully completed the Phase I/II clinical trial of its COVID-19 subunit vaccine candidate in India called Corbevax and received the approval to start the Phase III clinical trial from the Central Drugs Standard Control Organization (CDSCO) – Subject Expert Committee (SEC). The…

  • NEW COVID TREATMENT IN INDIA: ANTIBODY COCKTAIL BY ROCHE AND CIPLA

    NEW COVID TREATMENT IN INDIA: ANTIBODY COCKTAIL BY ROCHE AND CIPLA

    , , ,

    ·

    By

    Swikriti Chauhan

    –

    The monoclonal antibody cocktail, effective against the B.1.617 variant (found in India) is being imported by Roche, a Switzerland-based leading healthcare company and marketed in India through Cipla Ltd has recently received Emergency Use Authorization (EUA) from Central Drug Standard Control Organization (CDSCO) for the treatment of mild to moderate Covid-19 in adults and pediatric…

Follow Us

Category Name

Recent Posts

Tags

Autoimmunity cancer cancer research cancer therapy CDSCO covid-19 covid in children Diabetes drug Elderly Health FDA healthcare immune response Kerala mutations Nipah virus pandemic PCOS pharma Pharmaceutical market pharma sector protein-based vaccines sars-cov-2 therapy third wave Treatment vaccine variants WHO zydus cadila